Top stocks to buy: Stock recommendations for June 1, 2026 week – check list

Spread the love


Top stocks to buy: Stock recommendations for June 1, 2026 week - check list
Top stocks to buy today (AI image)

Stock market recommendations: Astra Microwave, and Shaily Engineering Plastics have been recommended by Motilal Oswal Wealth Management Research Desk as the top stocks to buy for the week starting June 1, 2026:

Stock Name Rating CMP (Rs) Target (Rs) Upside (%)
Astra Microwave Buy 1381 1580 14%
Shaily Engineering Plastics Buy 2990 3404 14%

Astra MicrowaveASTRA delivered a strong FY26 performance, with results surpassing estimates due to better margins and a 29% YoY rise in inflows to INR16.6b. Export momentum strengthened in 4QFY26, supported by higher-value RF systems and SDR-related opportunities. Key growth drivers for ASTRA include Uttam radar, QRSAM, Su-30 upgrades, EW systems, weather radars, and strategic space programs.The company targets FY27 revenue of INR13-14b, implying 15-20% YoY growth through stronger execution and higher production order contributions. It aims to nearly triple revenue by FY30-31, backed by strategic defense programs, improving operating leverage, and better cash-flow generation.We upgrade FY27/FY28 estimates to reflect stronger inflows and margins, with revenue/EBITDA/PAT expected to grow at 20%/17%/30% CAGR over FY26-28.Shaily Engineering PlasticsShaily Engineering Plastics has built nearly four decades of expertise in precision plastics manufacturing, serving global leaders across healthcare, consumer, personal care, appliances, automotive, and lighting industries. Its strong innovation capabilities and diversified customer base include IKEA, Unilever, Gillette, P&G, GE, and Garrett.SHEP’s healthcare business is witnessing strong momentum from rising GLP-1 and insulin pen demand after semaglutide patent expiries in key emerging markets. Backed by robust order visibility and sole-supplier engagements, the company plans a fivefold expansion in pen manufacturing capacity to over 150 million units by FY28.We expect the strong growth momentum to continue, supported by volume commitments from key Healthcare customers. We expect SHEP to clock 29%/38%/43% CAGR in revenue/EBITDA/PAT over FY26-28, with EBITDA margin sustaining at 32%+. We expect its RoE/RoCE to expand to ~28%/36% in FY28E.(Disclaimer: Recommendations and views on the stock market, other asset classes or personal finance management tips given by experts are their own. These opinions do not represent the views of The Times of India.)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *